(COP) CompuGroup Medical SE . KGaA - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A288904
COP: Software, Healthcare, Medical, Hospital, Pharmacy, Management, Systems
CompuGroup Medical SE & Co. KGaA is a leading global provider of e-health solutions, specializing in the development and implementation of software systems designed to streamline healthcare operations. The company operates through four primary segments: Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems. Each segment caters to distinct areas within the healthcare ecosystem, offering tailored solutions to enhance efficiency, patient care, and data management.
The Ambulatory Information Systems segment focuses on outpatient care, delivering practice management software for physicians, medical centers, and networks. This includes tools for scheduling, billing, and patient records, as well as supplementary digital solutions such as apps, internet, and intranet platforms. These systems are designed to optimize workflows for healthcare providers, enabling them to focus more on patient care and less on administrative tasks. Additionally, this segment offers solutions for larger medical facilities, practice associations, and care centers, ensuring comprehensive coverage of outpatient healthcare needs.
The Hospital Information Systems segment serves the inpatient care sector, providing clinical and administrative software solutions. These solutions are tailored for acute care hospitals, rehabilitation centers, multi-location hospital networks, and other healthcare institutions. The segment offers tools for care planning, service provision, and administrative management, ensuring seamless operations within complex healthcare environments. This includes software for laboratories, radiology departments, and other specialized units, enabling integrated care delivery and efficient resource allocation.
The Consumer and Health Management Information Systems segment emphasizes patient empowerment and data exchange. It develops digital healthcare applications, patient portals, and mobile apps, allowing individuals to access their health data securely. This segment also operates in the telematics infrastructure space, providing secure data exchange solutions for healthcare providers. Additionally, it offers decision-support tools for medical professionals, databases for medications and treatments, and solutions for the insurance industry, fostering a connected and informed healthcare ecosystem.
The Pharmacy Information Systems segment addresses the needs of pharmacies and related businesses. It offers software applications for inventory management, procurement, and retail operations. These solutions enable pharmacies to streamline their supply chains, monitor stock levels, and optimize their business processes. By automating administrative tasks,
Additional Sources for COP Stock
COP Stock Overview
Market Cap in USD | 830m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
COP Stock Ratings
Growth 5y | -68.9% |
Fundamental | -7.45% |
Dividend | 55.3% |
Rel. Strength Industry | -16.3 |
Analysts | - |
Fair Price Momentum | 19.90 EUR |
Fair Price DCF | 31.17 EUR |
COP Dividends
Dividend Yield 12m | 4.50% |
Yield on Cost 5y | 1.96% |
Annual Growth 5y | 14.87% |
Payout Consistency | 61.8% |
COP Growth Ratios
Growth Correlation 3m | 64.7% |
Growth Correlation 12m | -44.3% |
Growth Correlation 5y | -90.4% |
CAGR 5y | -14.79% |
CAGR/Max DD 5y | -0.18 |
Sharpe Ratio 12m | -0.08 |
Alpha | -19.55 |
Beta | 0.36 |
Volatility | 34.53% |
Current Volume | 14k |
Average Volume 20d | 26.6k |
As of March 15, 2025, the stock is trading at EUR 22.62 with a total of 13,992 shares traded.
Over the past week, the price has changed by +0.09%, over one month by -0.53%, over three months by +4.72% and over the past year by -15.56%.
Neither. Based on ValueRay Fundamental Analyses, CompuGroup Medical SE . KGaA is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.45 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COP as of March 2025 is 19.90. This means that COP is currently overvalued and has a potential downside of -12.02%.
CompuGroup Medical SE . KGaA has no consensus analysts rating.
According to ValueRays Forecast Model, COP CompuGroup Medical SE . KGaA will be worth about 21.5 in March 2026. The stock is currently trading at 22.62. This means that the stock has a potential downside of -4.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 25.5 | 12.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 21.5 | -5% |